[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial Louise Emmett , Shalini Subramaniam , Megan Crumbaker , Andrew Nguyen , Anthony M Joshua , Andrew Weickhardt , Sze-Ting Lee , Siobhan Ng , Roslyn J Francis , Jeffrey C Goh , David A Pattison , Thean Hsiang Tan , Ian D Kirkwood , Craig Gedye , Natalie K Rutherford , Shahneen Sandhu , Aravind Ravi Kumar , David Pook , Shakher Ramdave , David P Nadebaum , Mark Voskoboynik , Andrew D Redfern , William Macdonald , Laurence Krieger , Geoff Schembri , Wei Chua , Peter Lin , Lisa Horvath , Patricia Bastick , Patrick Butler , Alison Yan Zhang , Sonia Yip , Hayley Thomas , Ailsa Langford , Michael S Hofman , Margaret McJannett , Andrew James Martin , Martin R Stockler , Ian D Davis The Lancet Oncology（2024）
AI 理解论文
溯源树
样例
